Information:
Fel:
ID
27602
Beskrivning
Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00874432
Länk
https://clinicaltrials.gov/show/NCT00874432
Nyckelord
Versioner (1)
- 2017-11-21 2017-11-21 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
21 november 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Cardiovascular Disease NCT00874432
Eligibility Cardiovascular Disease NCT00874432
- StudyEvent: Eligibility
Similar models
Eligibility Cardiovascular Disease NCT00874432
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age > 60 years
boolean
C0001779 (UMLS CUI [1])
Blood Pressure
Item
bp 120/80 or higher *(bps will be checked weekly first 4 weeks to ensure < 130/80- if bp remains > 130/80 we will administer other bp meds per jnc vii guidelines)
boolean
C0005823 (UMLS CUI [1])
Chronic Kidney Disease stage | Glomerular Filtration Rate
Item
ckd stage 3 (gfr 30 - 59 ml/min) for ckd group; no ckd for control group
boolean
C1561643 (UMLS CUI [1,1])
C2074731 (UMLS CUI [1,2])
C0017654 (UMLS CUI [2])
C2074731 (UMLS CUI [1,2])
C0017654 (UMLS CUI [2])
Cardiovascular Diseases | Myocardial Infarction | Cerebrovascular accident Recurrent | New York Heart Association Classification
Item
known significant cvd (history of mi, recurrent stroke, or nyha class iii or greater).
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3,1])
C2945760 (UMLS CUI [3,2])
C1275491 (UMLS CUI [4])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3,1])
C2945760 (UMLS CUI [3,2])
C1275491 (UMLS CUI [4])
Serum potassium measurement
Item
serum potassium > 5.2 meq/l
boolean
C0302353 (UMLS CUI [1])
Angiotensin-converting-enzyme inhibitor allergy | Allergy to angiotensin II receptor antagonist
Item
known allergy or hypersensitivity to ace inhibitor or arb
boolean
C0571939 (UMLS CUI [1])
C2585204 (UMLS CUI [2])
C2585204 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Lacking
Item
female of childbearing age not practicing contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
current treatment with an ace-i or arb (note: can participate if on ace-i after 6 week washout period)
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0521942 (UMLS CUI [2])
Angioedema ACE-I induced
Item
history of ace-i induced angioedema
boolean
C0002994 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C0205263 (UMLS CUI [1,3])
C0003015 (UMLS CUI [1,2])
C0205263 (UMLS CUI [1,3])
Angioedemas, Hereditary | Idiopathic angioedema
Item
history of angioedema, hereditary or idiopathic
boolean
C0019243 (UMLS CUI [1])
C1304177 (UMLS CUI [2])
C1304177 (UMLS CUI [2])
Informed Consent Unable
Item
persons lacking consent capacity
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,2])
Proteinuria | Urine protein/creatinine ratio measurement Quantity
Item
500 mg/dl proteinuria on 2 consecutive spot urine protein/creat ratios
boolean
C0033687 (UMLS CUI [1])
C1096054 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1096054 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])